Erratum to: PAK signalling drives acquired drug resistance to MAPK inhibitors in BRAF-mutant melanomas (Nature, (2017), 10.1038/nature24040)

Authors

Hezhe Lu, University of Pennsylvania
Shujing Liu, University of Pennsylvania Perelman School of Medicine
Gao Zhang, The Wistar Institute
Bin Wu, University of Pennsylvania
Yueyao Zhu, University of Pennsylvania
Dennie T. Frederick, Massachusetts General Hospital Cancer Center
Yi Hu, Drexel University
Wenqun Zhong, University of Pennsylvania
Sergio Randell, The Wistar Institute
Norah Sadek, The Wistar Institute
Wei Zhang, University of Pennsylvania
Gang Chen, University of Pennsylvania
Chaoran Cheng, Department of Computer Science
Jingwen Zeng, University of Pennsylvania
Lawrence W. Wu, The Wistar Institute
Jie Zhang, Department of Computer Science
Xiaoming Liu, University of Pennsylvania Perelman School of Medicine
Wei Xu, Penn Medicine
Clemens Krepler, The Wistar Institute

Document Type

Syllabus

Publication Date

1-10-2019

Abstract

In this Letter, two relevant references were omitted; see the accompanying Amendment for details. The original Letter has not been corrected.

Identifier

85059750234 (Scopus)

Publication Title

Nature

External Full Text Location

https://doi.org/10.1038/s41586-018-0814-7

e-ISSN

14764687

ISSN

00280836

PubMed ID

30532003

First Page

E4

Issue

7738

Volume

565

Recommended Citation

Lu, Hezhe; Liu, Shujing; Zhang, Gao; Wu, Bin; Zhu, Yueyao; Frederick, Dennie T.; Hu, Yi; Zhong, Wenqun; Randell, Sergio; Sadek, Norah; Zhang, Wei; Chen, Gang; Cheng, Chaoran; Zeng, Jingwen; Wu, Lawrence W.; Zhang, Jie; Liu, Xiaoming; Xu, Wei; and Krepler, Clemens, "Erratum to: PAK signalling drives acquired drug resistance to MAPK inhibitors in BRAF-mutant melanomas (Nature, (2017), 10.1038/nature24040)" (2019). Faculty Publications. 7850.
https://digitalcommons.njit.edu/fac_pubs/7850